Skip to content

BIO

Bio-Rad Laboratories, Inc.

Stock

$369.14+13.57 (+3.82%)Close Oct 2, 2026

Key figures

MetricLast 12 months5-year CAGR
Revenue$2.6B+0.3%
Gross profit$1.3B−1.4%
Operating income$53M−35.5%
Net income$222M−27.6%
EPS$8.25−26.1%
Free cash flow$353M−4.7%